Acylpeptide hydrolase (APEH) sequence variants with potential impact on the metabolism of the antiepileptic drug valproic acid

De Turck BJ, Diltoer MW, Cornelis PJ, Maes V, Spapen HD, Camu F, Huyghens LP (1998) Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacin. J Antimicrob Chemother 42(4):563–564 Fujino T, Watanabe K, Beppu M, Kikugawa K, Yasuda H (2000) Identification of oxidized protein hydrolase of human erythrocytes as acylpeptide hydrolase. Biochim Biophys Acta 1478(1):102–112 Ishikawa T, Otaki H, Mizuta S, Kuriyama M, Onomura O, Higuchi N, Nakashima MN, Nakashima M, Ohyama K (2017) Computational study of the competitive binding of valproic acid glucuronide and carbapenem antibiotics to acylpeptide hydrolase. Drug Metab Pharmacokinet 32(4):201–207 Kobayashi K, Smith JA (1987) Acyl-peptide hydrolase from rat liver: characterization of enzyme reaction. J Biol Chem 262(24):11435–11445 Lineweaver H, Burk D (1934) The determination of enzyme dissociation constant. J Am Chem Soc 56(3):658–666 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275 Miranda Herrero MC, Alcaraz RAJ, Escudero VV, Fernández LSN, Fernández-Llamazares CM, Barredo VE, Vásquez LM, de Castro P (2015) Pharmacological interaction between valproic acid and carbapenem: what about levels in pediatrics? Eur J Paediatr Neurol 19(2):155–161 Nagai K, Shimizu T, Togo A, Takeya M, Yokomizo Y, Sakata Y, Matsuishi T, Kato H (1997) Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem/betamipron. J Antimicrob Chemother 39(2):295–296 Palmieri G, Cocca E, Gogliettino M, Valentino R, Ruvo M, Cristofano G, Angiolillo A, Balestrieri M, Rossi M, Di Costanzo A (2017) Low erythrocyte levels of proteasome and acyl-peptide hydrolase (APEH) activities in Alzheimer's disease: A sign of defective Proteostasis? J Alzheimers Dis 60(3):1097–1106 Palumbo R, Gogliettino M, Cocca E, Iannitti R, Sandomenico A, Ruvo M, Balestrieri M, Rossi M, Palmieri G (2016) APEH inhibition affects osteosarcoma cell viability via downregulation of the proteasome. Int J Mol Sci 17(10) pii: E1614 https://doi.org/10.3390/ijms17101614 Perrier J, Giardina T, Durand A, Puigserver A (2002) Specific enhancement of acylase I and acylpeptide hydrolase activities by the corresponding N-acetylated substrates in primary rat hepatocyte cultures. Biol Cell 94(1):45–54 Perrier J, Durand A, Giardina T, Puigserver A (2005) Catabolism of intracellular N-terminal acetylated proteins: involvement of acylpeptide hydrolase and acylase. Biochimie 87(8):673–685 Raphel V, Giardina T, Guevel L, Perrier J, Dupuis L, Guo XJ, Puigserver A (1999) Cloning, sequencing and further characterization of acylpeptide hydrolase from porcine intestinal mucosa. Biochim Biophys Acta 1432(2):371–381 Sass JO, Mohr V, Olbrich H, Engelke U, Horvath J, Fliegauf M, Loges NT, Schweitzer-Krantz S, Moebus R, Weiler P, Kispert A, Superti-Furga A, Wevers RA, Omran H (2006) Mutations in ACY1, the gene encoding aminoacylase 1, cause a novel inborn error of metabolism. Am J Hum Genet 78(3):401–409 Sass JO, Vaithilingam J, Gemperle-Britschgi C, Delnooz CC, Kluijtmans LA, van de Warrenburg BP, Wevers RA (2016) Expanding the phenotype in aminoacylase 1 (ACY1) deficiency: characterization of the molecular defect in a 63-year-old woman with generalized dystonia. Metab Brain Dis 31(3):587–592 Scaloni A, Jones W, Pospischil M, Sassa S, Schneewind O, Popowicz AM, Bossa F, Graziano SL, Manning JM (1992) Deficiency of acylpeptide hydrolase in small-cell lung carcinoma cell lines. J Lab Clin Med 120(4):546–552 Scaloni A, Ingallinella P, Andolfo A Jones W, Marino G, Manning JM (1999) Structural investigations on human erythrocyte acylpeptide hydrolase by mass spectrometric procedures. J Protein Chem 18(3):349–360 Shimizu K, Kiuchi Y, Ando K, Hayakawa M, Kikugawa K (2004) Coordination of oxidized protein hydrolase and the proteasome in the clearance of cytotoxic denatured proteins. Biochem Biophys Res Commun 324(1):140–146 Sommer A, Christensen E, Schwenger S, Seul R, Haas D, Olbrich H, Omran H, Sass JO (2011) The molecular basis of aminoacylase 1 deficiency. Biochim Biophys Acta 1812(6):685–690 Suzuki E, Naotoshi Y, Ogura Y, Nakai D, Kazuishi K, Nobuhiro K, S-i M, Okazaki O (2010) Identification of valproic acid glucuronide hydrolase as a key enzyme for the interaction of valproic acid with carbapenem antibiotics. Drug Metab Dispos 38(9):1538–1544 Suzuki E, Nakai D, Yamamura N, Kobayashi N, Okazaki O, Izumi T (2011) Inhibition mechanism of carbapenem antibiotics on acylpeptide hydrolase, a key enzyme in the interaction with valproic acid. Xenobiotica 41(11):958–963 Suzuki E, Nakai D, Ikenaga H, Fusegawa K, Goda R, Kobayashi N, Kuga H, Izumi T (2016) In vivo inhibition of acylpeptide hydrolase by carbapenem antibiotics causes the decrease of plasma concentration of valproic acid in dogs. Xenobiotica 46(2):126–131 Wen ZP, Fan SS, Du C, Yin T, Zhou BT, Peng ZF, Xie YY, Zhang W, Chen Y, Tang J, Xiao J, Chen XP (2016) Influence of acylpeptide hydrolase polymorphisms on valproic acid level in Chinese epilepsy patients. Pharmacogenomics 17(11):1219–1225 Yamin R, Bagchi S, Hildebrant R, Scaloni A, Widom RL, Abraham CR (2007) Acyl peptide hydrolase, a serine proteinase isolated from conditioned medium of neuroblastoma cells, degrades the amyloid-beta peptide. J Neurochem 100(2):458–467 Yamin R, Zhao C, O'Connor PB, McKee AC, Abraham CR (2009) Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide. Mol Neurodegener 4:33. https://doi.org/10.1186/1750-1326-4-33 Zeng Z, Rulten SL, Breslin C, Zlatanou A, Coulthard V, Caldecott KW (2017) Acylpeptide hydrolase is a component of the cellular response to DNA damage. DNA Repair 58:52–61